Literature DB >> 304327

Closing volume and flow volume abnormalities in alpha(1)-antitrypsin phenotype groups in a community population.

M D Lebowitz, R J Knudson, J O Morse, D Armet.   

Abstract

Alpha1-antitrypsin phenotype groups, found in a community population studied in Tucson, were compared by using the maximum expiratory flow volume curve and the single-breath nitrogen test, alone and in combination. Subjects 25 to 54 years of age were used for the comparison, among whom there were 728 Pi M, 29 Pi MZ, and 62 Pi MS phenotypes. None of the flow volume parameters or closing volume parameters was able to differentiate among the phenotype groups; subjects in groups heterozygous for alpha1-antitrypsin did not differ from individuals homozygous for Pi M with regard to any or all flow volume or closing volume parameters.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 304327     DOI: 10.1164/arrd.1978.117.1.179

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

1.  Assessment of alpha-1-antitrypsin deficiency heterozygosity as a risk factor in the etiology of emphysema. Physiological comparison of adult normal and heterozygous protease inhibitor phenotype subjects from a random population.

Authors:  D J McDonagh; S P Nathan; R J Knudson; M D Lebowitz
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

2.  Lung distensibility and airway function in intermediate alpha 1-antitrypsin deficiency (Pi MZ).

Authors:  S F Tattersall; R P Pereira; D Hunter; G Blundell; N B Pride
Journal:  Thorax       Date:  1979-10       Impact factor: 9.139

Review 3.  Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.

Authors:  C P Hersh; M Dahl; N P Ly; C S Berkey; B G Nordestgaard; E K Silverman
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

4.  Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.

Authors:  J E Gadek; J D Fulmer; J A Gelfand; M M Frank; T L Petty; R G Crystal
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

5.  Replacement therapy of alpha 1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects.

Authors:  J E Gadek; H G Klein; P V Holland; R G Crystal
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.